Abstract
Aminopeptidase N (APN) is a ubiquitous enzyme overexpressed on tumor cells and plays an important role in angiogenesis and metastasis of tumor. Bestatin as an effective inhibitor of aminopeptidase N is used for complementary treatment of cancer with other drugs. In this work, we reformed the structure of bestatin to a new derivative LYP3 to improve the water solubility and effectiveness. The inhibitory activity of LYP3 against APN was evaluated in vitro.
Keywords: Aminopeptidase N, bestatin, tumorigenesis, A549, ES-2, MDA-MB-231, tumor cells, angiogenesis, metastasis of tumor, met-alloprotease, angiotensin, enkephalin, neovascularization, leukemia, pharmacokinetics, biotransformation, L-serine benzylamine, flash chromatography, acylation, recrystallization, Water Solubility Assay, Lambert-Beer law, APN Inhibition Assay, L-leucine-p-nitroanilide, microsomal amino-peptidase, MMP-2 Inhibition Assay, ma-trix metalloproteinase-2 (MMP-2), MTT Assay, fetal bovine serum, diphenyltetrazolium bromide, mono-hydrochloride salt, APN high-expressed tumor cell line, APN low-expressed tumor cell line, immunostimulating effect
Medicinal Chemistry
Title: LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition
Volume: 7 Issue: 1
Author(s): Yepeng Luan, Chunhua Ma, Zhongguo Sui, Xuejian Wang, Jinhong Feng, Ning Liu, Fanbo Jing, Yan Wang, Minyong Li, Hao Fang and Wenfang Xu
Affiliation:
Keywords: Aminopeptidase N, bestatin, tumorigenesis, A549, ES-2, MDA-MB-231, tumor cells, angiogenesis, metastasis of tumor, met-alloprotease, angiotensin, enkephalin, neovascularization, leukemia, pharmacokinetics, biotransformation, L-serine benzylamine, flash chromatography, acylation, recrystallization, Water Solubility Assay, Lambert-Beer law, APN Inhibition Assay, L-leucine-p-nitroanilide, microsomal amino-peptidase, MMP-2 Inhibition Assay, ma-trix metalloproteinase-2 (MMP-2), MTT Assay, fetal bovine serum, diphenyltetrazolium bromide, mono-hydrochloride salt, APN high-expressed tumor cell line, APN low-expressed tumor cell line, immunostimulating effect
Abstract: Aminopeptidase N (APN) is a ubiquitous enzyme overexpressed on tumor cells and plays an important role in angiogenesis and metastasis of tumor. Bestatin as an effective inhibitor of aminopeptidase N is used for complementary treatment of cancer with other drugs. In this work, we reformed the structure of bestatin to a new derivative LYP3 to improve the water solubility and effectiveness. The inhibitory activity of LYP3 against APN was evaluated in vitro.
Export Options
About this article
Cite this article as:
Luan Yepeng, Ma Chunhua, Sui Zhongguo, Wang Xuejian, Feng Jinhong, Liu Ning, Jing Fanbo, Wang Yan, Li Minyong, Fang Hao and Xu Wenfang, LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition, Medicinal Chemistry 2011; 7 (1) . https://dx.doi.org/10.2174/157340611794072706
DOI https://dx.doi.org/10.2174/157340611794072706 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
Current Pharmaceutical Biotechnology Endocannabinoid Blockade and the Cardiovascular System
Current Drug Therapy Neuroprotective Therapy for HIV Dementia
Current HIV Research Role of Angiogenic Growth Factors in Psoriasis: A Review
Current Drug Metabolism Meet our Editorial Board Member
Current Cancer Therapy Reviews Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Barrier Strengthening and Anti-inflammatory Effect of Cucurbit Fruits on Intestinal Epithelial Cells In-vitro
Current Nutrition & Food Science Gastrin-Releasing Peptide as a Molecular Target for Inflammatory Diseases: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Obstructive Sleep Apnea Syndrome: Implications in Cardiovascular Disease
Current Respiratory Medicine Reviews Progress in Topical siRNA Delivery Approaches for Skin Disorders
Current Pharmaceutical Design Foreword: The Year in Review: Comments on Plants, Cyclodextrins, Microbiota, and Diabetes
Current Pharmaceutical Design Human Beta-Defensin-3: A Promising Antimicrobial Peptide
Mini-Reviews in Medicinal Chemistry Personalization of Targeted Therapy in Advanced Thyroid Cancer
Current Genomics Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Current Drug Metabolism Neuropeptides as Therapeutic Targets in Anxiety Disorders
Current Pharmaceutical Design Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
Current Medicinal Chemistry The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets The Integral Role of CD74 in Antigen Presentation, MIF Signal Transduction, and B Cell Survival and Homeostasis
Mini-Reviews in Medicinal Chemistry Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Current Drug Targets Autoimmune Hepatitis: A Childhood Disease
Current Pediatric Reviews